By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...
Johnson & Johnson (NYSE:JNJ) today announced results from the final analysis of the Phase 3 PROTEUS study showing the investigational use of apalutamide plus hormone therapy (androgen deprivation ...
Johnson & Johnson's prostate cancer drug Erleada, reportedly used alongside standard home-blocking therapy before and after ...
13don MSN
Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’
Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...
Can you have intimacy after prostate removal? Yes. It just might feel a little different. Recovery takes time, and everyone heals at their own pace. Some changes in intimate function are common after ...
Results from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiotherapy (COPORT) ...
After a prostatectomy, you’ll need to consider factors like catheter management, sexual activity, and mental health. Here’s how experts recommend approaching recovery.
Beyond the physical, a prostate cancer diagnosis carries significant emotional weight. Understanding this spectrum of ...
Following prostatectomy in patients with recurrent prostate cancer, researchers analyzed post–salvage radiotherapy prostate-specific antigen (PSA) values and the percentages of PSA decline to ...
Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results